Modeling of Production Industrial Process of the Drug Flocalin and Search of its Optimally Effective Dose for Treatment of Heart Diseases

Saved in:

Bibliographic Details
Date:	2013
Main Authors:	R. B. Strutynskyi, O. O. Moibenko, V. A. Chebanov, Yu. Horobets
Format:	Article
Language:	English
Published:	2013
Series:	Science and innovation
Online Access:	http://jnas.nbuv.gov.ua/article/UJRN-0000740770
Tags:	Add Tag No Tags, Be the first to tag this record!
Journal Title:	Library portal of National Academy of Sciences of Ukraine \| LibNAS

Institution

Library portal of National Academy of Sciences of Ukraine | LibNAS

Similar Items

The influence of activation of the atp-sensitive potassium channels by flocalin on the function of the cardiovascular system
by: R. B. Strutynskyi, et al.
Published: (2013)

Influence of flocalin on development of apoptosis and necrosis at anoxia-reoxygenation of culture rats neonatal cardiomyocytes
by: R. B. Strutynskyi, et al.
Published: (2013)

Drug flurenisid as an immunomodulator for the treatment of orphan diseases
by: M. M. Kovalenko
Published: (2017)

Current aspects of coronary heart disease diagnosis and treatment
by: O. M. Korzh
Published: (2020)

Biochemical mechanisms of KATP channels opener flocalin (medical form) cardioprotective action at ischemia–reperfusion of myocardium
by: R. B. Strutynskyi, et al.
Published: (2013)

Warfarin therapy in patients with coronary heart disease and atrial fibrillation: drug interactions and genetic sensitivity to warfarin
by: O. A. Panibratiuk, et al.
Published: (2020)

Use of combined nucleotide drug in treatment of ophthalmic manifestations of Sjogren&#039;s disease
by: D. M. Miroshnik
Published: (2020)

Features of cardiohaemodynamics of patients with ischemic heart disease and arterial hypertension when the amlodipine included in complex treatment of chronic heart failure
by: Yu. Ilikchiieva
Published: (2017)

Cardiomyocite hibernation and hepatization in ishemic heart disease
by: Yu. Kyiak, et al.
Published: (2015)

Dose enhancement effect of anticaner drugs associated with increased temperature in vitro
by: Istomin, Yu.P., et al.
Published: (2008)

Determination of leeptin level in patients with ischemic heart disease after surgical myocardial revascularization at the stage of restoration treatment
by: O. V. Kolodenko
Published: (2017)

Optimal control strategy for the administration of the third vaccine dose in the treatment of pandemic COVID-19
by: I. Khaloufi, et al.
Published: (2023)

Features of the course of the chronic rheumatic heart disease in modern conditions
by: O. O. Yakymenko, et al.
Published: (2019)

The clinical value and characteristic of parameters of lipid, carbohydrate metabolism, structural and functional parameters of the heart under the influence of standard treatment of patients with ischemic heart disease and arterial hypertension combined w
by: O. M. Radchenko, et al.
Published: (2012)

Survival predictors in elderly patients with chronic ischemic heart disease
by: A. L. Filipiuk, et al.
Published: (2012)

Chronic rheumatic heart disease and environmental pollution degree of atmosphere
by: G. S. Taktashov
Published: (2016)

Generalized optimization of drug transport in tumors
by: D. A. Kliushyn, et al.
Published: (2020)

Influence of flocalin and diltiazem on ion regulatory function under condions of hypoxic nephropathy
by: A. I. Hozhenko, et al.
Published: (2014)

Influence of dry carbon dioxide baths and interference therapy on endothelial dysfunction in complex treatment of patients with ischemic heart disease and coronary syndrome Kh
by: E. O. Penina
Published: (2016)

Models of development and compensation of hypoxic conditions under ischemic heart disease
by: T. A. Semchyk
Published: (2017)

The role of microelementosis in pathogenesis of respiratory disorders at chronic rheumatic heart disease
by: G. S. Taktashov
Published: (2015)

Descamed endotheliocytes and stages of their dergradation in blood in patients with iscemic heart disease
by: A. E. Pavlega, et al.
Published: (2020)

The experimental investigation of fibrinolytic system under the influence of flocalin in conditions of acute hypoxic kidney injury
by: A. I. Gozhenko, et al.
Published: (2017)

Dynamics of clinical and functional indexes of cardiorespiratory system at the use of nicorandil in the treatment of patients with bronchial asthma in combination with coronary heart disease I-II FS
by: N. A. Matsehora, et al.
Published: (2017)

The phenomenon of multi-drug resistance in the treatment of malignant tumors
by: Vtorushin, S.V., et al.
Published: (2014)

The phenomenon of multi-drug resistance in the treatment of malignant tumors
by: S. V. Vtorushin, et al.
Published: (2014)

The influence of antioxidant therapy on lipid peroxidation and antioxidant protection in ischemic heart disease
by: E. A. Pavlova
Published: (2017)

Hypertensive heart disease in the adult population evacuated from the exclusion zone, in the post- emergency period
by: O. A. Kapustynska, et al.
Published: (2017)

Optimization of targeted drug delivery from systems of microneedles
by: S. I. Liashko, et al.
Published: (2017)

Sanatorium rehabilitation of patients with coronary heart disease after surgical myocardial revascularization conjunction with osteoarthritis
by: K. D. Babov, et al.
Published: (2015)

New approaches to the treatment of neurodegenerative diseases
by: M. V. Skok
Published: (2018)

Study of asymmetric dimethylarginine level in patients with ischemic heart disease without coronary atherosclerotic lesion
by: D. M. Sebov, et al.
Published: (2015)

New fluorine-containing openers of atp-sensitive potassium channels flokalin and tioflokalin inhibit calcium-induced mitochondrial pore opening in rat hearts
by: N. A. Strutynska, et al.
Published: (2013)

Preoperative verification of comorbidity in patients with high-risk coronary heart disease on the eve of surgical myocardial revascularization
by: O. K. Hohaieva
Published: (2021)

Optimal control of drug delivery from microneedles systems
by: S. I. Ljashko, et al.
Published: (2018)

Rationale for the differentiated appointment of vazoactive preparations in the treatment of patients with ischemic heart disease in combination with arterial hypertension dependent on the degree of pulmonary hypertension and / or the stage of chronic hear
by: N. A. Matsehora, et al.
Published: (2017)

Results of clinical application of thermoelectricdevice for the treatment of skin diseases
by: L. I. Anatychuk, et al.
Published: (2018)

Results of clinical application of thermoelectricdevice for the treatment of skin diseases
by: L. I. Anatychuk, et al.
Published: (2018)

Concomitant coronary heart disease as a factor in reducing the quality of life of patients with chronic pancreatitis
by: L. S. Babinets, et al.
Published: (2019)

The changes in the level of cytokines, glomerotubular markers, cardiohemodynamics in chronic heart failure and its combination with kidney disease
by: P. G. Kravchun, et al.
Published: (2012)